Predictors of death from natural causes in schizophrenia: 10-year follow-up of a community cohort

Social Psychiatry and Psychiatric Epidemiology

Volumn 47, Issue 6, 2012, Pages 843-847

  Brown, Steve ^a   Mitchell, Clemence ^b  

^a SOUTHERN HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Lifestyle; Mortality; Physical health; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; CAUSE OF DEATH; COMORBIDITY; COMPARATIVE STUDY; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; FOOD PREFERENCE; HEALTH BEHAVIOR; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; MORTALITY; NEUROPSYCHOLOGICAL TEST; OBESITY; ONSET AGE; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGICAL ASPECT; PSYCHOSIS; QUESTIONNAIRE; REGRESSION ANALYSIS; SCHIZOPHRENIA; SMOKING; UNITED KINGDOM;

AGE DISTRIBUTION; AGE OF ONSET; AGED; ALCOHOL DRINKING; ANTIPSYCHOTIC AGENTS; CAUSE OF DEATH; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; FOOD PREFERENCES; GREAT BRITAIN; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OBESITY; PROPORTIONAL HAZARDS MODELS; PSYCHOTIC DISORDERS; QUESTIONNAIRES; REGRESSION ANALYSIS; SCHIZOPHRENIA; SMOKING;

EID: 84863725103     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-011-0392-6     Document Type: Article

References (34)

1. Rantanen H, Koivisto A-M, Salokangas R, Helminen M, Oja H, Pirkola S, Wahlbeck K, Joukamaa M (2009) Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalisation. Soc Psychiatry Psychiatr Epidemiol 44:135-142
2. Saha S, Chant D, McGrath J (2007) A systematic review of mortality in schizophrenia. Is the differential mortality gap worsening over time? Arch Gen Psychiatry 64:1123-1131
3. Kendler K (1986) A twin study of mortality in schizophrenia and neurosis. Arch Gen Psychiatry 43:643-649
4. Brown S, Kim M, Mitchell C, Inskip H (2010) Twenty five year mortality of a community cohort with schizophrenia. Br J Psychiatry 196:116-121
5. World Health Organisation (2009) Global health risks. Mortality and burden of disease attributable to selected major risks. WHO, Geneva
6. McEvoy J, Meyer J, Goff D, Nasrallah H, Davis S, Sullivan L, Meltzer H, Hsiao J, Stroup T, Lieberman J (2005) Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 80:19-32
7. Brown S, Birtwistle J, Roe L, Thomson C (1999) The unhealthy lifestyle of people with schizophrenia. Psychol Med 29:697-701
8. McCreadie R (2003) Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 183:534-539
9. Okumura Y, Ito H, Kobayashi M, Mayahara K, Matsumoto Y, Hirakawa J (2010) Prevalence of diabetes and antipsychotic prescription patterns in patients with schizophrenia: a nationwide retrospective cohort study. Schizophr Res 119:145-152
10. Saarni S, Saarni S, Fogelholm M, Heliovaara M, Perälä J, Suvisaari J, Lönnqvist J (2009) Body composition in psychotic disorders: a general population survey. Psychol Med 39:801-811
11. Druss B, Bradford W, Rosenheck R, Radford M, Krumholz H (2001) Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry 58:565-572
12. Tihonen J, Lönnquist J, Wahlbeck K, Laukka T, Niskanen L, Tanskanen A, Haukka J (2009) 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 374:620-627
13. Henderson C, Thornicroft G, Glover G (1998) Inequalities in mental health. Br J Psychiatry 173:105-109
14. Kilbourne A, Morden N, Austin K, Ilgen M, McCarthy J, Dalack G, Blow F (2009) Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. Gen Hosp Psychiatry 31:555-563
15. Gibbons J, Horn S, Powell J, Gibbons J (1984) Schizophrenia patients and their families. A survey in a psychiatric service based on a DGH unit. Br J Psychiatry 144:70-77
16. World Health Organisation (1992) Schedules for clinical assessment in neuropsychiatry. WHO, Geneva
17. Roe L, Strong C, Whiteside C, Neil A, Mant D (1994) Dietary intervention in primary care: validity of the DINE method for diet assessment. Fam Pract 11:375-381
18. The Information Centre (2008) Health survey for England 2006. Cardiovascular disease and risk factors in adults. The Information Centre
19. Godin G, Shephard R (1985) A simple method to assess exercise behaviour in the community. Can J Appl Sport Sci 10:141-146
20. Bennett N, Dodd T, Flatley J, Freeth S, Bolling K (1995) Health survey for England 1993. HMSO, London
21. Walters S (2009) What is a Cox model? http://www.whatisseries. co.uk
22. Working Group of the Royal College of Physicians, Psychiatrists and General Practitioners (1995) Alcohol and the heart in perspective. Sensible limits reaffirmed. J R Coll Phys Lond 29:266-271
23. SPSS (2009) SPSS for windows, version 17.0. Lead Technologies, Inc, Chicago
24. Marder S, Essock S, Miller A, Buchanan R, Casey D et al (2004) Physical health monitoring in patients with schizophrenia. Am J Psychiatry 161:1334-1349
25. NICE (2009) Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care. Nice clinical guideline 82. National Institute for Health and Clinical Excellence, London
26. Brunner E, Stallone D, Juneja M, Bingham S, Marmot M (2001) Dietary assessment in Whitehall II: comparison of 7 d diet diary and food-frequency questionnaire and validity against biomarkers. Br J Nutr 86:405-414
27. Fletcher G, Balady G, Blair S, Blumenthal J, Casperson C et al (1996) Statement on exercise: benefits and recommendations for physical activity programs for all Americans. Circulation 94:857-862
28. Copeland L, Zeber J, Wang C-P, Parchamn M, Lawrence V, Valenstein M, Miller A (2009) Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilisation. BMC Health Serv Res 9:127
29. Tenorio-Martinez R, Lara-Munoz M, Medina-Mora E (2009) Measurement of problems in activities and participation in patients with anxiety, depression and schizophrenia using the ICF checklist. Soc Psychiatry Psychiatr Epidemiol 44:377-384
30. Gray R, Leese M, Bindman T, Becker L, Burti A, David K, Gournay K, Kikkert M, Koeter M, Puschner B (2006) Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial. Br J Psychiatry 189:508-514
31. Gray R, Wykes T, Edmonds M, Leese M, Gournay K (2004) Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: cluster randomised controlled trial. Br J Psychiatry 185:57-162
32. Velligan D, Diamond P, Mintz J, Maples N, Li X, Zeber J, Ereshefsky L, Lam Y-W, Castillo D, Miller A (2008) The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull 34:483-493
33. Roberts L, Geppert C (2004) Ethical use of long-acting medications in the treatment of severe and persistent mental illness. Compr Psychiatry 45:161-167
34. Campion J, Checinski K, Nurse J (2008) Review of smoking cessation treatments for people with mental illness. Adv Psychiatr Treat 14:208-216